234 related articles for article (PubMed ID: 9342362)
1. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.
Goletz TJ; Klimpel KR; Arora N; Leppla SH; Keith JM; Berzofsky JA
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12059-64. PubMed ID: 9342362
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
Carbonetti NH; Tuskan RG; Lewis GK
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
[TBL] [Abstract][Full Text] [Related]
3. Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein.
Zhang Y; Kida Y; Kuwano K; Misumi Y; Ikehara Y; Arai S
Microbiol Immunol; 2001; 45(2):119-25. PubMed ID: 11293477
[TBL] [Abstract][Full Text] [Related]
4. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
5. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.
Rothwell SW; Wassef NM; Alving CR; Rao M
Immunol Lett; 2000 Oct; 74(2):141-52. PubMed ID: 10996390
[TBL] [Abstract][Full Text] [Related]
7. Modified anthrax fusion proteins deliver HIV antigens through MHC Class I and II pathways.
McEvers K; Elrefaei M; Norris P; Deeks S; Martin J; Lu Y; Cao H
Vaccine; 2005 Jul; 23(32):4128-35. PubMed ID: 15964481
[TBL] [Abstract][Full Text] [Related]
8. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
9. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
[TBL] [Abstract][Full Text] [Related]
10. A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen.
Kushner N; Zhang D; Touzjian N; Essex M; Lieberman J; Lu Y
Proc Natl Acad Sci U S A; 2003 May; 100(11):6652-7. PubMed ID: 12740437
[TBL] [Abstract][Full Text] [Related]
11. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
Doe B; Steimer KS; Walker CM
Eur J Immunol; 1994 Oct; 24(10):2369-76. PubMed ID: 7523139
[TBL] [Abstract][Full Text] [Related]
12. Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol.
Cao H; Agrawal D; Kushner N; Touzjian N; Essex M; Lu Y
J Infect Dis; 2002 Jan; 185(2):244-51. PubMed ID: 11807699
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
Wagner R; Böltz T; Deml L; Modrow S; Wolf H
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
[TBL] [Abstract][Full Text] [Related]
14. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
15. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin.
Lomas M; Hanon E; Tanaka Y; Bangham CRM; Gould KG
J Gen Virol; 2002 Mar; 83(Pt 3):641-650. PubMed ID: 11842259
[TBL] [Abstract][Full Text] [Related]
16. Both CD4+ and CD8+ T cells respond to antigens fused to anthrax lethal toxin.
Shaw CA; Starnbach MN
Infect Immun; 2008 Jun; 76(6):2603-11. PubMed ID: 18347032
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
18. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
Yang B; Hahn YS; Hahn CS; Braciale TJ
J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
[TBL] [Abstract][Full Text] [Related]
19. Delivery of antigens to the MHC class I pathway using bacterial toxins.
Goletz TJ; Klimpel KR; Leppla SH; Keith JM; Berzofsky JA
Hum Immunol; 1997 May; 54(2):129-36. PubMed ID: 9297531
[TBL] [Abstract][Full Text] [Related]
20. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
De Haan L; Hearn AR; Rivett AJ; Hirst TR
Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
